Odyssey Therapeutics, Inc. (ODTX) — Dilution Risk Analysis
Current Snapshot
Odyssey Therapeutics, Inc. (ODTX) has a DilutionWatch score of 52/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 52/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: XBRL 2, 4 6, 3 1, 8-K 1.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-11316-xbrl_convertible |
| xbrl | 2026-06-30 | xbrl-11316-xbrl_warrant |
| 4 | 2026-05-13 | 0001999371-26-010652 |
| 3 | 2026-05-12 | 0001012975-26-000416 |
| 4 | 2026-05-12 | 0001012975-26-000417 |
| 8-K | 2026-05-11 | 0001193125-26-216899 |
| 4 | 2026-05-11 | 0001193125-26-217583 |
| 4 | 2026-05-11 | 0001193125-26-217584 |
| 4 | 2026-05-11 | 0001193125-26-217585 |
| 4 | 2026-05-11 | 0001193125-26-217586 |
Dilution Risk Drivers
No shelf, ATM, cash-runway, or share-growth risk-driver values were present in the current source payload.
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 52/10) Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.